Home Amines 118753-70-1
118753-70-1,MFCD06858679
Catalog No.:AA00388B

118753-70-1 | N-Boc-N,N-bis(2-chloroethyl)amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$6.00   $4.00
- +
5g
97%
in stock  
$8.00   $6.00
- +
25g
95%
in stock  
$21.00   $15.00
- +
50g
95%
in stock  
$41.00   $29.00
- +
100g
95%
in stock  
$82.00   $57.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00388B
Chemical Name:
N-Boc-N,N-bis(2-chloroethyl)amine
CAS Number:
118753-70-1
Molecular Formula:
C9H17Cl2NO2
Molecular Weight:
242.1428
MDL Number:
MFCD06858679
SMILES:
ClCCN(C(=O)OC(C)(C)C)CCCl
Properties
Computed Properties
 
Complexity:
174  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
2  
Rotatable Bond Count:
6  
XLogP3:
2.3  

Upstream Synthesis Route

[1]Tetrahedron,2004,vol.60,#22,p.4875-4878

[2]Patent:US2003/187020,2003,A1,

[3]Patent:WO2006/46024,2006,A1,.Locationinpatent:Page/Pagecolumn146

[4]Patent:WO2007/125321,2007,A2,.Locationinpatent:Page/Pagecolumn140-141

[5]Patent:US2003/229067,2003,A1,.Locationinpatent:Page26

[6]Patent:CN107501209,2017,A,.Locationinpatent:Paragraph0020

[7]Patent:CN104876934,2017,B,.Locationinpatent:Paragraph0062-0064

[8]EuropeanJournalofMedicinalChemistry,2017,vol.138,p.543-551

[9]Polyhedron,2012,vol.43,#1,p.104-113

[10]JournalofMedicinalChemistry,1992,vol.35,#11,p.2033-2039

[11]BioorganicandMedicinalChemistryLetters,2015,vol.25,#16,p.3234-3245

[12]Patent:WO2013/10453,2013,A1,.Locationinpatent:Page/Pagecolumn125;126

[13]Patent:WO2004/4722,2004,A1,.Locationinpatent:Page/Pagecolumn50-51

[14]JournaloftheChemicalSociety,PerkinTransactions1,2000,#20,p.3444-3450

[15]Patent:US2007/27173,2007,A1,.Locationinpatent:Page/Pagecolumn115

[16]Patent:EP1714961,2006,A1,.Locationinpatent:Page/Pagecolumn18

[17]Patent:WO2009/67202,2009,A1,.Locationinpatent:Page/Pagecolumn196

[18]BioorganicandMedicinalChemistry,2006,vol.14,#21,p.7213-7230

[19]Patent:US2005/70549,2005,A1,

[20]Patent:US2016/31908,2016,A1,.Locationinpatent:Paragraph1202;1203

[21]JournalofMedicinalChemistry,1992,vol.35,#21,p.3919-3927

[22]Patent:US2005/176722,2005,A1,.Locationinpatent:Page/Pagecolumn11

[23]Patent:US5635510,1997,A,

[24]Patent:US5824690,1998,A,

[25]Patent:US2007/142349,2007,A1,.Locationinpatent:Page/Pagecolumn25

[26]Patent:US2005/54628,2005,A1,.Locationinpatent:Page/Pagecolumn30

[27]Patent:WO2009/51715,2009,A1,.Locationinpatent:Page/Pagecolumn31-32

[28]Patent:WO2009/61681,2009,A2,.Locationinpatent:Page/Pagecolumn64-65

[29]Patent:US2007/21609,2007,A1,.Locationinpatent:Page/Pagecolumn9

[30]Patent:WO2011/46771,2011,A1,.Locationinpatent:Page/Pagecolumn136

[31]NewJournalofChemistry,2013,vol.37,#4,p.1174-1179

[32]JournalofMedicinalChemistry,2013,vol.56,#22,p.9275-9295

[33]Patent:WO2015/73310,2015,A1,.Locationinpatent:Page/Pagecolumn43;44

[34]Patent:WO2015/70367,2015,A1,.Locationinpatent:Page/Pagecolumn42;43

[35]Patent:US9518048,2016,B2,.Locationinpatent:Page/Pagecolumn26

[36]MedChemComm,2018,vol.9,#8,p.1340-1350

[37]Patent:WO2008/152149,2008,A1,.Locationinpatent:Page/Pagecolumn59

[38]Patent:US6339090,2002,B1,.Locationinpatent:Example3

[1]Patent:US2009/264400,2009,A1,.Locationinpatent:Page/Pagecolumn92-93

[2]Patent:US2009/264407,2009,A1,.Locationinpatent:Page/Pagecolumn66

[3]Patent:US5661163,1997,A,

[4]Patent:US6358959,2002,B1,.Locationinpatent:Example1

[5]Patent:WO2014/194242,2014,A2,.Locationinpatent:Paragraph00525-00526

[1]Patent:US2003/13720,2003,A1,

[1]Patent:US6319932,2001,B1,

[2]Patent:US5977115,1999,A,

[3]Patent:US6228870,2001,B1,

[1]Patent:WO2006/51290,2006,A2,.Locationinpatent:Page/Pagecolumn120-121;133

[2]Patent:WO2006/136829,2006,A2,.Locationinpatent:Page/Pagecolumn119

Downstream Synthesis Route
2461-35-0    75476-78-7    118753-70-1   
1'-(2-hydroxy-1,2,3,4-tetrahydronaphth-3-yl)spiro<6-bromo-1H-indene-1,4'-piperidine> 
 
1'-(2-hydroxy-1,2,3,4-tetrahydronaphth-3-yl)spiro<5-bromo-1H-indene-1,4'-piperidine> 

[1]JournalofMedicinalChemistry,1994,vol.37,p.2574-2582

75476-78-7    118753-70-1   
5-bromo-1'-(tert-butoxycarbonyl)spiro<1H-indene-1,4'-piperidine> 
  158628-80-9 

[1]JournalofMedicinalChemistry,1994,vol.37,p.2574-2582

75476-78-7    118753-70-1   
C13H14BrN*ClH 
 
C13H14BrN*ClH 

[1]JournalofMedicinalChemistry,1994,vol.37,p.2574-2582

[1]Locationinpatent:schemeortableChen,Xiaoqi;Mihalic,Jeff;Fan,Pingchen;Liang,Lingming;Lindstrom,Michelle;Wong,Sylvia;Ye,Qiuping;Fu,Ying;Jaen,Juan;Chen,Jin-Long;Dai,Kang;Li,Leping[BioorganicandMedicinalChemistryLetters,2012,vol.22,#1,p.363-366]

[2]CurrentPatentAssignee:SIMCEREPHARMACEUTICALGROUP-CN108250128,2018,ALocationinpatent:Paragraph1093;1095;1096;1097

[3]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2008/68159,2008,A1Locationinpatent:Page/Pagecolumn28;29

[4]CurrentPatentAssignee:KOWACOMPANY,LTD.-US2010/22572,2010,A1Locationinpatent:Page/Pagecolumn13

[5]Tantry,SubramanyamJ.;Degiacomi,Giulia;Sharma,Sreevalli;Jena,LalitKumar;Narayan,Ashwini;Guptha,Supreeth;Shanbhag,Gajanan;Menasinakai,Sreenivasaiah;Mallya,Meenakshi;Awasthy,Disha;Balakrishnan,Gayathri;Kaur,Parvinder;Bhattacharjee,Deepa;Narayan,Chandan;Reddy,Jitendar;NaveenKumar;Shandil,Radha;Boldrin,Francesca;Ventura,Marcello;Manganelli,Riccardo;Hartkoorn,RubenC.;Cole,StewartT.;Panda,Manoranjan;Markad,ShankarD.;Ramachandran,Vasanthi;Ghorpade,SandeepR.;Dinesh,Neela[BioorganicandMedicinalChemistryLetters,2015,vol.25,#16,p.3234-3245]

[6]CurrentPatentAssignee:JACOBIOPHARMACEUTICALSGROUPCOLTD-WO2018/172984,2018,A1Locationinpatent:Paragraph80;81

[7]CurrentPatentAssignee:JACOBIOPHARMACEUTICALSGROUPCOLTD-CN110143949,2019,ALocationinpatent:Paragraph0396-0399

[8]CurrentPatentAssignee:PIRAMALENTERPRISESLIMITED-WO2015/28960,2015,A1Locationinpatent:Page/Pagecolumn87

[9]CurrentPatentAssignee:ShanghaiInstituteofMateriaMedica(in:CAS);CHINESEACADEMYOFSCIENCES-CN109666027,2019,ALocationinpatent:Paragraph0173;0174;0176

[10]Evans,BenE.;Leighton,JamesL.;Rittle,KennethE.;Gilbert,KevinF.;Lundell,GeorgeF.;etal.[JournalofMedicinalChemistry,1992,vol.35,#21,p.3919-3927]

[11]Chambers;Baker;Billington;Knight;Middlemiss;Wong[JournalofMedicinalChemistry,1992,vol.35,#11,p.2033-2039]

[12]CurrentPatentAssignee:PANMIRAPHARMACEUTICALS,INC.-WO2009/61681,2009,A2Locationinpatent:Page/Pagecolumn65

[13]CurrentPatentAssignee:YAKULTHONSHACOLTD;JAPANESEFOUNDATIONFORCANCERRESEARCH;INSTITUTEOFPHYSICALANDCHEMICALRESEARCH(RIKEN)-EP3480198,2019,A1Locationinpatent:Paragraph0256;0257

[14]CurrentPatentAssignee:ShanghaiInstituteofMateriaMedica(in:CAS);CHINESEACADEMYOFSCIENCES-EP3985007,2022,A1Locationinpatent:Paragraph0119-0120

[15]CurrentPatentAssignee:ShanghaiInstituteofMateriaMedica(in:CAS);CHINESEACADEMYOFSCIENCES-EP3985007,2022,A1Locationinpatent:Paragraph0119-0120

[16]CurrentPatentAssignee:ShanghaiInstituteofMateriaMedica(in:CAS);CHINESEACADEMYOFSCIENCES-EP3985007,2022,A1Locationinpatent:Paragraph0119-0120

[1]JournalofMedicinalChemistry,1999,vol.42,p.4778-4793

[2]Patent:WO2009/51715,2009,A1.Locationinpatent:Page/Pagecolumn31-32

[3]JournalofMedicinalChemistry,2011,vol.54,p.4773-4780

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:118753-70-1 Molecular Formula|118753-70-1 MDL|118753-70-1 SMILES|118753-70-1 N-Boc-N,N-bis(2-chloroethyl)amine